Home › NCT05628974

Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)

Who can join

Ages 18 to 65 · All sexes

Inclusion Criteria:

* Adults aged 18 to 65 years old
* Healthy Male \& Female voluntary participants

Exclusion Criteria:

* Individuals who have taken anticoagulant or antiplatelet medications in past 10 days
* Individuals with hematopoetic diseases

About the study

This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.

Sponsor: The Cleveland Clinic · Participants: 400 · Started: May 1, 2020

Contact the study team

• Scott Cameron, MD, PhD · Phone: 216-444-1680

Official record on ClinicalTrials.gov — NCT05628974

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.